← Back

Wire · regulatory

Senators Johnson, Paul Release Email Showing Top FDA Official Expressing Concern Over ...

Published

16 August 2026

Topic

regulatory

Sectors

Healthtech Infrastructure

Geography

United States

Source

Read at ronjohnson.senate.gov

Verified

Fusion42 · 16 August 2026 · Fusion42 review

In May 2021, FDA Acting Commissioner Dr. Janet Woodcock expressed concern over unrecognized adverse events after COVID-19 vaccination and called for a study, but her warnings were apparently ignored by officials including Dr. Fauci and the CDC.

This Wire brief sits within Fusion42's coverage of Healthtech Infrastructure. Wire is Fusion42's founder-focused intelligence feed: each story is connected to the funds and startups it names — every one with a live profile on Raise or Scout — so founders can follow the capital and the momentum behind the headline rather than just the headline itself. Wire analysis is one of the live surfaces Arthur reasons over.

◆ The Wire takeaway

You must reassess trust in US vaccine regulatory processes as internal FDA concerns were sidelined despite early signals of serious side effects; this opens room for ventures that prioritise transparent vaccine safety data and real-time adverse event tracking.

Related on Wire

Topics

Healthtech Infrastructurefdacovid-vaccineadverse-eventsregulatory-oversightpublic-health